FT.com / Search

1-10 of 465,201 results for IN RE ORTHOPAEDIC IMPLANT DEVICE ANTITRUST LITIGATION

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

August 1, 2006
S&N salesman in US anti-trust probe
...the latest anti-trust investigation into the US implant market...seen the orthopaedic company and...to rival implant makers including...prices of orthopaedic products...was sent in late October...believed any anti-trust behaviour...into the orthopaedic products world. In 2005 it started...surgeons and implant makers... By Lisa Urquhart
April 1, 2005
Orthopaedic stocks fall as probe widens
Shares of orthopaedic implant makers such as Johnson...subpoenas from prosecutors in New Jersey. The subpoenas...investigation. Zimmer, a rival orthopaedic implant maker, said it had not...industry's share prices in the near term. News of... By Christopher Bowe in New York
February 9, 2010
Rebuff to Delta as JAL sticks with American
...Narita airport in Tokyo.Immunity from antitrust rules became possible in December when the US and Japan signed an...carrier, All Nippon Airways, is pursuing antitrust immunity for a venture with United...Kyocera technology group, who was brought in by the government last month to oversee...for its part, had warned that US anti-trust authorities would balk at granting immunity...years, however, when the government re-privatises the airline to recover... By Jonathan Soble in Tokyo
November 3, 2006
S&N has few choices other than Biomet
...the thumbs up by many in the City. "If Smith...pole position in the orthopaedic market. But a merger...There are risks inherent in this deal. But the...revenue from its core orthopaedic business, which manufactures...sales are generated in the US. The global...are carrying out an anti-trust investigation into the US implant market. An independent... By Salamander Davoudi
3:22am
BHP Billiton cautious on recovery
...lending as part of efforts to ease a boom in credit conditions.Mr Kloppers did not...stressed the need to continue investing in the group’s global operations, including...progress on that venture, which requires anti-trust clearance from the European regulator...present form [when BHP acquired Billiton in 2001],” Mr Kloppers said.“We believe... By Peter Smith in Sydney
July 18, 2006
J&J blames slow growth on Merck
...the US drugmaker, withdrew Vioxx in September 2004 because of relative...theorised that extraordinarily high orthopaedic sales early last year stemmed from...patients without access to cox-2s. The orthopaedic implant market is also seeing more pricing...competition and interest from insurers in the costs of such devices. Medical...J&J’s other critical medical device Cypher, a drug-coated coronary stent... By Christopher Bowe in New York
December 19, 2006
Biomet deal puts S&N in the spotlight
...Nephew to acquire Biomet, the US orthopaedic devices manufacturer, for $10.9bn...has failed to secure a large deal. In 2003, the company bid £1.5bn...Such a deal would be unlikely to face antitrust issues. Yesterday, some analysts...private equity groups have long invested in the healthcare industry, they are...rivals, vying for the $22bn global orthopaedic implant market. Biomet put itself up for... By James Politi and Christopher Bowe in New York and Salamander,Davoudi in London
July 19, 2006
J&J blames slow growth on Merck
...quarter of slower medical device growth. The US health products...slowed to about 6 per cent in part because orthopaedic implants faced tough comparisons...that extraordinarily high orthopaedic sales early last year stemmed...access to cox-2s. The orthopaedic implant market is also seeing more...and interest from insurers in the costs of such devices... By Christopher Bowe in New York
June 27, 2006
Marks and Spencer looks good fit with talk of earnings upgrades
...Committee is completed on Thursday. In spite of closing 0.5 per cent lower at...mining companies Falconbridgeand Inco in a $40bn (£22bn) deal. Mick Davis...subpoenaed over suspected violations of antitrust law relating to sales of orthopaedic implant devices. De Vere was the top performer...for clients this year, against £1bn in 2005, and traders believe the business... By Neil Hume and Robert Orr
February 4, 2010
Eni moves to satisfy watchdog
...assets, including its majority stake in the TAG pipeline which brings Russian...Italy via Austria, to satisfy European antitrust regulators.Paolo Scaroni, chief executive...expected the company’s 89 per cent stake in TAG to be sold to an Italian state entity...pursued a couple of cases of alleged anti-trust breaches against it.Shares in Eni fell 2.4 per cent on Thursday. By Nikki Tait in Brussels and Vincent Boland in Milan